NASDAQ$SLN

Silence Therapeutics Plc · Q1 2023 earnings

Q1 2023 earnings · · Investor relations

Headline financials

Total Revenue

$13.8M

Previous: $7.68M+79.9%
EPS (adj)

-$0.12

Previous: -$0.12+0.0%

Revenue & EPS history

Silence Therapeutics · Revenue · Quarterly

$13.8M

Q1 2023+79.9%vs Q1 2022
Beat estimate in 6 of 9 quarters(67%)
ActualEstimate

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q1 2023

Historical avgQ1 2023

-2.2%

Avg return

Earnings day

-1.1%

Avg return

5 days after

+4.4%

Avg return

30 days after

35%

7 / 20 earnings

Positive

+11.3%

Q2 2023

Best reaction

-16.7%

Q3 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q2 2024———
Q1 2026-5.8%-7.7%-16.3%
Q4 2025-6.0%+4.2%-0.7%
Q3 2025+2.9%+7.7%+11.5%
Q2 2025+0.2%+5.1%+7.0%
Q1 2025-1.7%+26.6%+31.3%
Q4 2024-1.0%-6.1%-27.9%
Q3 2024-16.7%-54.3%-57.7%
Q4 2023-8.0%-7.3%-14.4%
Q3 2023+4.6%+1.0%+74.5%
Q2 2023+11.3%+14.2%+62.6%
Q1 2023-7.2%+1.9%+3.9%
Q4 2022-6.9%-6.6%-35.8%
Q3 2022+10.7%+17.4%+32.1%
Q2 2022-2.3%-3.6%+22.1%
Q1 2022-1.8%-14.6%-6.1%
Q4 2021-0.8%+6.7%+0.6%
Q2 2021-14.3%-11.8%-9.7%
Q1 2021+0.2%+13.2%+9.6%
Q4 2020+0.2%+0.2%+13.7%
Q3 2020-2.5%-9.0%-13.3%
Q2 2020———
Q1 2020———
Q4 2019———
Q3 2019———
Q2 2019———
Q1 2019———
Q4 2018———
Q3 2018———
Q2 2018———
Q1 2018———
Q4 2017———
Q3 2017———
Q2 2017———
Q1 2017———
Q4 2016———
Q3 2016———
Q2 2016———
Q1 2016———
Q4 2015———
Q3 2015———
Q2 2015———
Q1 2015———
Q4 2014———
Q3 2014———
Q2 2014———
Q1 2014———
Q4 2013———
Q3 2013———
Q2 2013———
Q1 2013———
Q4 2012———
Q3 2012———

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro